MS Statistics Intern at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Enrolled in and attending a graduate-level curriculum leading to a Master’s degree in Statistics, Biostatistics, or MSPH with a concentration in Statistics or Biostatistics at the time of the internship
Proficient in statistical programming languages/software such as R, SAS, Spotfire, WinBUG, etc
Interpersonal communication skills for effective customer consultation
Teamwork and leadership skills
Technical expertise and application with working knowledge of experimental design and statistical analysis
Self-management skills with a focus on results for timely and accurate completion of competing deliverables
Resource management skills
Creativity and innovation
Demonstrated problem solving ability and critical thinking

Responsibilities

Utilize statistics and programming skills on the project that will have impact in the Statistics, Data and Analytics organization
Lead the project by understanding the background and impact
Collaborate with stakeholders in the project
Present to the organization on the technical aspects and the impact of the project
Introduce and apply innovative thinking to the project
Present project highlights, findings, recommendations, and general internship accomplishments to senior leaders and stakeholders at the conclusion of the internship

Skills

Statistics

Statistical Programming

Data Sciences

Analytics

Project Management

Stakeholder Collaboration

Presentation Skills

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free